Skip to main content

Table 1 Group features

From: Serum AGE/RAGEs as potential biomarker in idiopathic pulmonary fibrosis

Patient characteristics Control IPF cHP fNSIP
Subjects (n) 12 62 22 20
Gender (Male/Female) 9 / 3 53 / 9 10 / 12 5 / 15
Age (yr.) 69.11 ± 5.97 68.43 ± 8.57 64.74 ± 11.36 63.33 ± 11.62
Smoking (Former/Never) 5 / 7 43 / 19 12 / 10 5 / 15
Pack-years 20.23 ± 26.07 31.28 ± 20.74 19.25 ± 27.39 20.70 ± 11.67
Smoking cessation (yr.) 7.67 ± 9.07 15.17 ± 8.69 18.56 ± 10.38 9.00 ± 4.58
% FVC 116.20 ± 14.23** 78.71 ± 20.33 82.59 ± 15.98 81.40 ± 25.93
% DLCO 103.10 ± 2.62** 50.41 ± 20.75 56.98 ± 19.40 59.11 ± 27.67
% TLC 112.75 ± 18.31** 79.79 ± 18.69 80.88 ± 17.82 83.61 ± 19.90
  1. Data represent the mean ± SD, cHP chronic hypersensitivity pneumonitis, DLCO diffusing capacity for carbon monoxide, fNSIP fibrotic non-specific interstitial pneumonia, FVC forced vital capacity, IPF idiopathic pulmonary fibrosis, TLC Total lung capacity. (**) p-value < 0.01